AzTrials
AzTrials

HemophiliaNCT07851922

Validity and Reliability of the Figure-of-Eight Walking and Weight-Bearing Lunge Tests in Hemophilia

An observational study of Hemophilia, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Recurrent joint bleeding (hemarthrosis) occurs in 70-80% of cases of hemophilia. The three most frequently affected joints are the synovial joints of the ankle, knee, and elbow. Among these, the ankle and knee are the most common sites of bleeding, accounting for 80% of cases (Stephensen et al., 2009). Read more about this study

Who is it for?
Ages 18 to 65 years, men only
Conditions the study is for
Hemophilia
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Aug 2026to 15 Oct 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: Hemophilia patients aged with 18-65 years

Who may be able to join

  • a diagnosis of hemophilia A
  • severe, moderate or mild clinical severity of hemophilia
  • a history of bleeding in at least one knee or ankle joint
  • being aged 18-65
  • the ability to walk 20 meters independently without a cane or crutches

Who cannot join

  • inability to stand unsupported; presence of an orthopaedic, neurological, and/or psychiatric condition affecting balance or physical performance
  • visual impairment
  • inhibitor positivity
  • inability to bear weight through the lower extremities
  • major lower-extremity surgery within the previous 6 months
  • haemarthrosis within the previous 2 weeks.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Necati Muhammed TAT, Assistant Professor contact

+905075083347

necatimuhammedtat@yyu.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Van Yuzuncu Yil University

    Van, 65080

    Necati Muhammed Tat, Assistant Professor, +905075083347

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Validity and Reliability of the Figure-eight Walking Test and Weight-Bearing Lunge Test in Adult Patients With Hemophilia.

Recurrent joint bleeding (hemarthrosis) occurs in 70-80% of cases of hemophilia. The three most frequently affected joints are the synovial joints of the ankle, knee, and elbow. Among these, the ankle and knee are the most common sites of bleeding, accounting for 80% of cases (Stephensen et al., 2009). This susceptibility stems from factors such as the fact that the knee and ankle are weight-bearing joints and are highly exposed to trauma.

Hemophilia treatment aims to reduce the frequency of bleeding episodes through prophylactic factor replacement; however, joint bleeding can recur despite treatment, potentially leading to permanent joint damage. This joint disease causes pain, reduced range of motion, and potential impairment of postural balance, while also increasing the risk of falls.

Read more

Due to its complexity and significance for the individual, gait assessment is a crucial component in evaluating mobility, functional capacity, and rehabilitation progress across various populations, including the elderly, individuals with neurological disorders, and those recovering from injuries. Various clinical tests and technological tools are available to measure different aspects of gait, such as walking ability, endurance, adaptability, and fatigue. Timed walking tests-such as the Timed Up and Go (TUG) test, the 2-Minute Walk Test (2MWT), the 6-Minute Walk Test (6MWT), the 10-Meter Walk Test (10MWT), and the Timed 25-Foot Walk Test (T25FW)-measure gait speed, endurance, and overall walking ability. A common feature of these tests is that they involve walking along a straight path with little to no change in direction; while this makes them effective in standardized clinical settings, they are relatively less suitable for assessing the complex mobility demands of daily life. In contrast, the Figure-8 Walk Test (F8WT) requires continuous changes in direction and turning, thereby challenging anticipatory postural adjustments, spatial navigation, and motor planning. Literature has demonstrated that walking along a curved path challenges dynamic balance and increases gait variability, revealing deficits-particularly in the elderly and in individuals with neurological or cognitive impairments-that are not apparent during straight-line walking.

In their daily lives, people frequently encounter curved paths and changes in walking direction-such as walking around a table, turning a corner, or avoiding an obstacle. The ability to successfully adapt one's gait and safely execute turns or changes in direction is fundamental to an individual's mobility and independence.

The Timed Up and Go (TUG) test is a widely used, performance-based clinical assessment tool for measuring lower-extremity function, mobility, and fall risk in individuals; its reliability and validity are well-established. The ABC scale is a 16-item measure used to assess balance confidence while performing specific activities both indoors and outdoors; it has also been proven reliable and valid. Among older adults, a score of 76% or lower indicates a risk of falling. The Weight-Bearing Lunge Test (WBLT), which assesses ankle dorsiflexion mobility, has demonstrated excellent test-retest reliability in patients with hemophilia, even in those with limited joint damage. Another test that is reliable and shows strong correlation with other functional measures in individuals with hemophilia is the Four Square Step Test (FSST). The FSST is associated with age rather than the severity of hemophilia and provides clinicians with information regarding the speed and ability to change direction and step over obstacles. The Y Balance Test (YBT) is a dynamic balance and postural control assessment that is increasingly preferred for use with patients with hemophilia in recent years.

Since the F8WT requires continuous changes of direction, it demands greater dynamic balance, spatial planning, and gait adaptation. It is important to examine the validity and reliability of the F8WT-which assesses change of direction, dynamic balance, agility, and functional mobility-in patients with hemophilia. The fact that the F8WT is easy to administer, quick to complete, and requires minimal equipment offers significant advantages for clinical use. However, no study evaluating the psychometric properties of this test in patients with hemophilia has been found in the literature. The aim of this study is to investigate the test-retest reliability and construct validity of the F8WT and WBLT in adult patients with hemophilia.

Conditions
Hemophilia
Keywords
Hemophilia, outcome measures, validity, Figure-of-eight walk test, weight-bearing lunge test
Medical subject headings
Hemophilia A

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07851922
Study groupRoleWhat they receive
HemophiliaNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Figure-of-eight walk

    The Figure-of-Eight Walk Test (F8WT) involves sitting on and rising from a chair. First, a rectangle measuring 3.6 meters in length and 2.4 meters in width is marked on the floor, and cones are placed at the two rear corners (along the length). A chair is positioned 2.4 meters away from the cones on either side, and the participant sits facing forward. Upon the start signal, the participant rises from the chair, walks clockwise around the rear-right cone as quickly as possible, returns to the chair, and sits down. Immediately afterward, they stand up, walk counter-clockwise around the rear-left cone, return to the chair, and sit down; this procedure is repeated twice, with an interval of 3-4 days between sessions.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  2. Weight-Bearing Lunge

    In this test, participants stand barefoot facing a wall; the test foot is positioned parallel to a measuring tape fixed to the floor, while the opposite foot is placed one foot-length behind. Participants perform a forward lunge, lightly touching their kneecap against the wall while maintaining heel contact. The test foot is moved backward in increments of approximately 1 cm until heel contact can no longer be maintained, and the distance between the toes and the wall is recorded in centimeters. The lunge position will be used to measure ankle dorsiflexion.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

Secondary outcomes (7)
  1. Timed Up and Go

    Participants are instructed to rise from a chair with armrests (seat height: 42-46 cm), walk a distance of 3 meters (m) to a cone in a comfortable and safe manner, and then return to the chair and sit down again. The time taken to complete the task is measured using a stopwatch with a precision of 1/100th of a second. Timing begins with the word "start" following a 3-second countdown, and the timer is stopped when the participant is fully seated. TUG tests are administered by the same evaluator on two separate occasions, and the average time is recorded.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  2. Five Times Sit to Stand

    It measures the time it takes for a person to stand up from a seated position and sit back down five times. To perform the test, the person must sit on a chair with their arms crossed over their chest and their back resting against the backrest. Therefore, the chair should have a straight backrest, and a seat height of 42-46 cm is recommended. Upon instruction, the person must stand up fully and then return to the seated position; this action is to be repeated five times, and the activity should be performed as quickly as possible.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  3. Four Square Step Test

    It is a widely used dynamic balance test that clinically assesses an individual's ability to step forward, sideways, and backward over objects. The test consists of four wands of equal width arranged in a cross pattern. Participants are instructed to step sequentially in a clockwise direction into the squares numbered 1 through 4-specifically in the order 2, 3, 4, 1, 4, 3, 2, and 1-as quickly as possible without striking the wands (Figure 2). A shorter completion time indicates better performance. This measure demonstrates high validity and reliability. Completion times of 15 seconds or longer indicate a risk of falling.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  4. Activities-specific Balance Confidence Scale

    It is a 16-item questionnaire used to assess an individual's self-perceived level of balance confidence while performing activities of daily living. The total ABC score ranges from 0 to 100, with higher scores indicating greater balance confidence.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  5. Y-Balance Test

    Participants will perform the test barefoot while standing on one leg. While maintaining balance on one leg, they are required to extend the opposite leg as far as possible in the anterior, posterior, medial, and lateral directions. Prior to the test, leg length is measured from the anterior superior iliac spine to the distal end of the medial malleolus. Participants complete six practice trials in each direction to familiarize themselves with the procedure, followed by three recorded test trials. The maximum reach distance in each direction is recorded and normalized to leg length.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  6. HJHS

    Joint health will be assessed using the Hemophilia Joint Health Score (HJHS). The HJHS bilaterally evaluates the knee, elbow, and ankle joints-the sites where bleeding most frequently occurs in hemophilia. The total score is calculated by adding the gait score to the scores of the six index joints. It is a valid and reliable scoring system frequently used in the literature to evaluate joint health in hemophilia. In our study, in addition to the index score for each joint, the total lower-extremity index joint score will also be calculated.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

  7. Ankle Dorsifleksiyon Angle

    With the patient lying in the supine position, a roll is placed under the knee. The axis of the goniometer is aligned with the lateral malleolus. The stationary arm is held parallel to the long axis of the fibula. The movable arm follows the lateral border of the fifth metatarsal. The ankle is moved into dorsiflexion. The final dorsiflexion angle is recorded in degrees. A high degree indicates good ankle mobility.

    Measured: Two measurements: Baseline and another 3-4 days after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study start30 Aug 2026
  3. Primary completion15 Oct 2026 (estimated)
  4. Study completion15 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
36 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07851922
Sponsor's protocol ID
2026/07-04
Status last verified
Sep 2026
First submitted
25 Sep 2026
Last updated
1 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Hemophilia, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Necati Muhammed TAT, Assistant Professor (+905075083347, necatimuhammedtat@yyu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Figure-of-eight walk (time frame: Two measurements: Baseline and another 3-4 days after baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in